Innovative Health SolutionsEGF Theramed Health's focus on genomic and regenerative therapies positions it well in the growing personalized healthcare market, offering potential for future revenue growth and competitive advantage through innovation.

Strategic CollaborationsStrategic partnerships for co-developing treatments can enhance product offerings and provide additional revenue streams, supporting long-term growth and innovation in the healthcare sector.

Product And Service DiversificationDiversified revenue streams from proprietary products and services reduce dependency on a single income source, potentially stabilizing earnings and supporting sustainable business operations.

Bears Say

Financial InstabilityThe company's negative equity and cash flow issues indicate significant financial instability, which could hinder its ability to invest in growth opportunities and sustain operations long-term.

Zero Revenue GenerationThe lack of revenue generation suggests operational challenges and an inability to monetize its offerings, posing a risk to financial health and long-term viability.

High LeverageHigh leverage and negative equity increase financial risk, limiting flexibility and potentially leading to solvency issues if not addressed through strategic financial management.

TMED FAQ

What was EGF Theramed Health’s price range in the past 12 months?

EGF Theramed Health lowest stock price was C$0.06 and its highest was C$0.13 in the past 12 months.

What is EGF Theramed Health’s market cap?

EGF Theramed Health’s market cap is C$697.00K.

When is EGF Theramed Health’s upcoming earnings report date?

EGF Theramed Health’s upcoming earnings report date is Jun 02, 2026 which is in 95 days.

How were EGF Theramed Health’s earnings last quarter?

EGF Theramed Health released its earnings results on Feb 24, 2026. The company reported -C$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.006.

Is EGF Theramed Health overvalued?

According to Wall Street analysts EGF Theramed Health’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does EGF Theramed Health pay dividends?

EGF Theramed Health does not currently pay dividends.

What is EGF Theramed Health’s EPS estimate?

EGF Theramed Health’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does EGF Theramed Health have?

EGF Theramed Health has 11,616,665 shares outstanding.

What happened to EGF Theramed Health’s price movement after its last earnings report?

EGF Theramed Health reported an EPS of -C$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of EGF Theramed Health?

Currently, no hedge funds are holding shares in TSE:TMED

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

EGF Theramed Health

EGF Theramed Health Corp. provides psychedelic drugs for the treatment of mental health. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.